Three selected naturally occurring oxyprenylated secondary metabolites, namely 2-hydroxy4-isopentenyloxyacetophenone (1), 4-geranyloxy-2hydroxyacetophenone (2), 4-farnesyloxyacetophenone (3), and derricidin (4) were synthesized and their inhibitory potency against soybean 15-lipoxygenase evaluated. Compounds 1 and 4 showed the most potent inhibitory activity with IC 50 values of 2.5 µM and 0.6 µM.
Lipoxygenases represent a large class of non heme iron-containing proteins which are able to promote the hydroperoxidation of polyunsaturated fatty acids containing a cis,cis-1,4-pentadiene structure such as arachidonic and linoleic acids [1] . Such enzymes are nowadays well known to play a pivotal role in many acute and chronic syndromes like inflammation, asthma, cancer, stroke, allergy, and several other inflammation-based diseases [2] . Stating their importance as a therapeutic target, there is currently a huge interest in the chemistry and pharmacology of novel lipoxygenase inhibitors. Although several molecules have been synthesized and biologically tested in this regard, the majority exhibit too many side effects, so preventing their use as effective therapeutic remedies [3] .
Oxyprenylated natural products, 3,3-dimethylallyoxy-(C 5 ), geranyloxy-(C 10 ), and the farnesyloxy-(C 15 ) related compounds, represent a group of secondary metabolites that were considered for years to be biosynthetic intermediates of the more widespread C-prenylated derivatives. These natural compounds have been recognized in the last twenty years as interesting and valuable biologically active phytochemicals. About 350 compounds have been isolated and structurally characterized from plants, primarily from the families Rutaceae and Apiaceae, comprising several edible vegetables and fruits, bacteria, and fungi. The phytochemistry and pharmacology of oxyprenylated secondary metabolites was reviewed in 2007 [4] . As a continuation of our ongoing studies aimed to characterize the phytochemical and pharmacological properties of oxyprenylated secondary metabolites, in this paper we briefly report the in vitro soybean 15-lipoxygenase inhibitory activity of four naturally occurring acetophenones, namely 2-hydroxy4-isopentenyloxyacetophenone (1), 4-geranyloxy-2hydroxyacetophenone (2), 4-farnesyloxy-2-hydroxyacetophenone (3) and the chalcone derricidin (4), also known as cordoin. Our investigation aims to reveal potential anti-inflammatory properties of the title phytochemicals. The use of commercially available soybean 15-lipoxygenase to this purpose is a meaningful way as this enzyme of plant origin shares close structural similarities to the human isoform [4] . [5] .
All phytochemicals were chemically synthesized following the already reported procedure [6] . Briefly, to obtain compounds 1-3 a selective alkylation of commercially available 2,4-dihydroxyacetophenone in position 4 with the corresponding alkyl bromide (3,3-dimethylallyl, geranyl, or farnesyl) promoted by DBU was accomplished. Derricidin (4) was synthesized from compound 1 by an aldol condensation with benzaldehyde in an ethanolic alkaline medium [7] .
The four products so obtained were then assessed in vitro for their inhibitory capacities against soybean 15-lipoxygenase using the methodology recently reported by Sadeghian and co-workers [7] . We used the known lipoxygenase inhibitors caffeic acid and farnesyl phenyl ether (FPE) as reference compounds. Results, expressed as IC 50 values, are reported in Table 1 .
As reported in the Table 1 , of the four phytochemicals tested, marked differences in activity were recorded. In particular, no activity was revealed for 4-geranyl-2-hydroxyacetophenone ( and -farnesyl-2-hydroxyacetophenone (3), while 2-hydroxy-4isopentenyloxyacetophenone 1 and derricidin 4 were found to be from about 10-to about 40-fold more potent than caffeic acid and more to equally effective when compared to farnesyl phenyl ether, both used as reference compounds. Examination of the oxyprenylated secondary metabolites herein under investigation reveals how the presence of a 3,3-dimethylallyloxy side chain in position 4 of the acetophenone core may be claimed as the main structural feature and determinant of the observed soybean 15-lipoxygenase inhibitory effect. Moreover, the only difference between 2-hydroxy-4-isopentenyloxyacetophenone (1) and derricidin (4) being the presence of an -unsaturated conjugated carbon-carbon double bond, it can be hypothesized that the 5-fold greater potency of compound 4 may be due to the presence of such a functionality.
The hypothesis that -unsaturated conjugated carbon-carbon double bonds may play a key role in determining the inhibitory effects against 15-lipoxygenase is enforced by the similar findings reported by Sadeghian and co-workers regarding natural and semisynthetic oxyprenylated coumarins [8] . However, the pattern of results recorded by these authors is substantially different in other aspects from those reported in the present study. In fact, for what concerns the type of oxyprenylated side chain, Sadeghian and coworkers found that the longer was the chain, the higher was the activity on 15-lipoxygenase, with the farnesyloxy compounds being equally or slightly more potent than farnesyl phenyl ether. What we recorded is exactly the contrary, the natural compounds with a 5 carbon oxy-chain being largely more effective than either geranyloxy or farnesyloxy phytochemicals.
Further studies to account for this discrepancy are needed and are now in course in our laboratory, as well as synthesis of structural analogues of compounds 1 and 4 to be tested as further and novel inhibitors of soybean 15-lipoxygenase.
In conclusion, the findings described herein indicate that isopentenyloxyacetophenones and chalcones could be regarded as potential novel and effective lipoxygenase inhibitory agents with a potency comparable with or higher than the known inhibitors. The present study represents an extension of the current knowledge in the field of natural and semisynthetic oxyprenylated compounds as agents able to modulate lipoxygenase functions. It is in fact the third study in the literature reporting that oxyprenylated acetophenones and chalcones, other than the previously described O-terpenyl aminoacids, anthranilate, phenylalkyl alcohols [5] and coumarins [8] , may act as promising and potentially effective antiinflammatory agents. For these reasons, the results of the present study could be considered as a topic for future studies aimed at better defining the pharmacological profile of the title and other oxyprenylated secondary metabolites and of their semisynthetic structural analogues and to develop novel series of lead compounds.
